PembrolizumabHypothyroidism: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1969卷 / 1期

关键词：

D O I：

10.1007/s40278-023-44773-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：307 / 307

相关论文

共 50 条

[21] PembrolizumabHypothyroidism and focal segmental glomerulosclerosis: case report
[J]. Reactions Weekly, 2021, 1884 (1) : 356 - 356
[22] PembrolizumabHypothyroidism and adrenocorticotropic hormone deficiency: case report
[J]. Reactions Weekly, 2020, 1791 (1) : 210 - 210
[23] Ipilimumab/nivolumab/pembrolizumabHypothyroidism and autoimmune thyroiditis: case report
[J]. Reactions Weekly, 2018, 1712 (1) : 313 - 313
[24] PembrolizumabHypothyroidism and elevated serum creatinine levels: case report
[J]. Reactions Weekly, 2020, 1803 (1) : 197 - 197
[25] PembrolizumabHypothyroidism: 2 case reports
[J]. Reactions Weekly, 2020, 1824 (1) : 237 - 237
[26] PembrolizumabHypothyroidism and acquired generalised lipodystrophy secondary to drug toxicity: case report
[J]. Reactions Weekly, 2020, 1816 (1) : 269 - 269
[27] Levothyroxine sodium/pembrolizumabHypothyroidism, drug overdose and adrenal insufficiency: case report
[J]. Reactions Weekly, 2022, 1909 (1) : 328 - 328
[28] PembrolizumabHypothyroidism, off-label-use and lack-of-efficacy: case report
[J]. Reactions Weekly, 2022, 1920 (1) : 397 - 397
[29] PembrolizumabHypothyroidism, primary adrenal insufficiency and type 1 diabetes mellitus: case report
[J]. Reactions Weekly, 2018, 1733 (1) : 267 - 267
[30] PembrolizumabHypothyroidism
[J]. Reactions Weekly, 2023, 1984 (1) : 436 - 436

← 1 2 3 4 5 →